Therapeutic Areas

The Science-First Full Service CRO and Regulatory Partner for Cardiovascular Clinical Research

Scientific Thinking to Rapidly Advance Your Cardiovascular Clinical Trial

As leading life-shortening illnesses, cardiovascular diseases demand critical attention for prevention and treatment globally. At Veristat, we have built a team of scientific-minded experts to help sponsors advance their novel cardiovascular therapy to success. Nearly 50% of our global team members have cardiovascular clinical trial and regulatory expertise and have supported clients with more than 90 clinical trials and consulting projects. 

Developing a cardiovascular therapy? Let’s Talk. 


Cardiovascular clinical trials and consulting projects


in Rare/Ultra-Rare Indications


Marketing Application Approval Success Rate

Clinical Trial and Regulatory Expertise for Cardiovascular Studies

Our solutions span the entire clinical development and regulatory approval process, and are offered as a comprehensive, all-inclusive solution or as functional support. We provide strategic guidance for informed decision-making, operational support to mitigate trial risks, statistical knowledge to prove safety and efficacy, medical oversight to ensure patient safety, and regulatory expertise to achieve approval success. 

Our experts are poised to launch your Cardiovascular study and get lifesaving treatments to patients faster: 

Scientific Excellence for Cardiovascular Clinical Research 

Cardiovascular Drugs & Biologics

  • Atherosclerosis 
  • Heart Attack 
  • Hypertension 
  • Infantile Hemangioma 
    And more… 

Cardiac Devices & Combo Products

  • Artificial Heart 
  • Cardiac Imaging 
  • EKG Monitoring 
  • Intravascular IV Catheter 
  • And more…
Cardiac Medical Devices and Combination Products

Find out how our clinical research expertise can help with your next study or program.


Learn More with These Resources

Fact Sheet

Medical Writing Fact Sheet

Fact Sheet

Adaptive Design Fact Sheet

Webinar Presentation

Future Trends on European Regulations on Medicines